The drug will be used in conjunction with other treatments that yield results.

Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...

Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared with standard chemotherapy, and their risk of death dropped by 60 percent, ...

Revolution Medicines' application for a drug to treat metastatic pancreatic cancer was accepted for review by the Food and Drug Administration.

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...

New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...

A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.

An image of a pancreatic cancer cell. Revolution Medicines got a standing ovation in a presentation of the biotech's pancreatic cancer drug. The announcement of a successful late-stage treatment that ...